A Systematic Review of the Literature on Chronic Kidney Disease Following Liver Transplantation

24 May 2022: Review Paper

Hitomi Miyata ^1ADE* , Yoshiaki Morita ^2ADE , Anil Kumar ^3DE

DOI: 10.12659/AOT.935170

Ann Transplant 2022; 27:e935170

Table 8 Graft survival for the included studies.

Author, year [ref]	n	Timepoint	Population, n	Graft survival, n (%)
Chen WY et al, 2017 []²³	14	17 months	–	14 (100)
Chen WY et al, 2017 []²³	28	17 months	–	28 (100)
Jochmans I et al, 2017 []²⁸	21	12 months	–	17 (81.0)
Jochmans I et al, 2017 []²⁸	59	12 months	–	54 (91.5)
Dopazo C et al, 2018 []²⁹	20	12 months	–	19 (95.0)
Pascher A et al, 2015 []³⁰	49	6 months	FAS, 49	Graft loss, 3 (6.5)^*
	51	6 months	FAS, 51	Graft loss, 1 (2.0)^*
	49	6 months	FAS, 49	Graft loss, 3 (6.2)^*
	51	6 months	FAS, 51	Graft loss, 2 (3.9)^*
Saliba F et al, 2017 []²²	93	6 months	ITT, 90	90 (100)
Saliba F et al, 2017 []²²	95	6 months	ITT, 93	92 (98.9)
^* Graft loss defined as need for retransplantation or death due to liver failure, reported as Kaplan-Meier estimates. AKI – acute kidney injury; ATG – anti-human T-lymphocyte globulin; BID – twice daily; EC-MPS – enteric-coated mycophenolate sodium; FAS – full analysis set; ITT – intention-to-treat; MMF – mycophenolate mofetil; OLT – orthotopic liver transplantation; QD – once daily; TAC – tacrolimus.